THY1 and hepatocellular carcinoma: In the TME, tumor-associated macrophage (TAM)-derived EVs significantly downregulate miRNA-125a and miRNA-125b (miRNA-125a/b targets CD90, a stem cell marker for HCC) and promote the progression of HCC (196).